SURGICAL APPARATUS FOR ANEURYSMS
    1.
    发明申请
    SURGICAL APPARATUS FOR ANEURYSMS 审中-公开
    外科手术装置

    公开(公告)号:US20130066413A1

    公开(公告)日:2013-03-14

    申请号:US13581728

    申请日:2011-03-02

    IPC分类号: A61F2/84 A61F2/88

    摘要: The present application discloses a surgical apparatus for aneurysms comprising: a stent, a delivery guide wire, an introducer sheath and a microcatheter, wherein: the stent is a self-expanding stent; the delivery guide wire outside of which the stent is restrained to is provided in a lumen of the introducer sheath; the introducer sheather is connected with the microcatheter, with lumnes communicating, to form a passageway through which the delivery guide wire and the stent are delivered into a human body. The surgical apparatus for aneurysms provided in the examples of the present application is able to deliver and release the stent which has high density and is super soft to a vascular lesion. A lattice structure of the stent is of high coverage at the vascular lesion such that the stent released into the vessel prodeces the same effects as healing of parent vessel, and thus improves the treatment of vascular aneurysms.

    摘要翻译: 本申请公开了一种用于动脉瘤的手术装置,包括:支架,输送导丝,导引鞘和微导管,其中:支架是自扩张支架; 引导器鞘的内腔中设置有限制支架的输出导丝, 引导器护套与微导管连接,柱子连通,形成通道,输送导丝和支架通过该通道输送到人体内。 在本申请的实施例中提供的用于动脉瘤的外科手术装置能够输送和释放具有高密度且对于血管损伤是超柔软的支架。 支架的格子结构在血管损伤处具有高覆盖度,使得释放到血管中的支架产生与母体血管愈合相同的效果,从而改善血管动脉瘤的治疗。

    MEDICAL GUIDE WIRE
    2.
    发明申请
    MEDICAL GUIDE WIRE 审中-公开
    医疗指导线

    公开(公告)号:US20130023853A1

    公开(公告)日:2013-01-24

    申请号:US13521300

    申请日:2011-01-25

    IPC分类号: A61M25/09

    摘要: A medical guide wire comprises a metal core (1), a coil (2), a delivery element (3) and a boss (4). The metal core (1) has a variable-diameter structure, which consists of a linear structure (1-3), a stepped structure (1-2) and a linear structure (1-1) from a proximal end to a distal end. The number of the coil (2) is one or more, and the coil(s) is/are fixed on the linear structure (1-1) and the stepped structure (1-2) at the distal end of the metal core (1). The number of the delivery element (3) is one or more, and the delivery element(s) is/are fixed to the stepped structure (1-2) of the metal core (1). The boss (4) is fixed on the stepped structure (1-2) of the metal core (1) behind the delivery element (3). When the medical guide wire is delivering an implant instrument, the delivery element on the medical guide wire makes each segment of the implant instrument receive even resistance by rubbing the inner wall of the implant instrument, thereby integrally delivering the implant instrument into the human lumen.

    摘要翻译: 医疗用导线包括金属芯(1),线圈(2),输送元件(3)和凸台(4)。 金属芯(1)具有可变直径结构,其包括从近端到远端的直线结构(1-3),阶梯结构(1-2)和线性结构(1-1) 。 线圈(2)的数量是一个或多个,并且线圈固定在金属芯的远端处的直线结构(1-1)和台阶结构(1-2)上 1)。 输送元件(3)的数量是一个或多个,并且输送元件固定到金属芯(1)的台阶结构(1-2)上。 凸台(4)固定在金属芯(1)的分拣元件(3)后面的台阶结构(1-2)上。 当医疗导丝传送植入物仪器时,医疗导丝上的输送元件通过摩擦植入器械的内壁而使植入器械的每个部分接收均匀的阻力,从而将植入器械整体地输送到人体腔内。

    ELECTROPHORETIC DISPERSION
    5.
    发明申请
    ELECTROPHORETIC DISPERSION 审中-公开
    电泳分散

    公开(公告)号:US20130193385A1

    公开(公告)日:2013-08-01

    申请号:US13360482

    申请日:2012-01-27

    申请人: Yu Li Hui Du Haiyan Gu

    发明人: Yu Li Hui Du Haiyan Gu

    IPC分类号: H01B1/12 H01B1/20 H01B1/00

    摘要: The present invention is directed to an electrophoretic dispersion comprising charged pigment particles dispersed in a solvent or solvent mixture, wherein the pigment particles have an average aggregation size more than 2 times their primary size. The electrophoretic dispersion of the present invention is capable of improving image bistability through adjusting the aggregation size of the charged pigment particles.

    摘要翻译: 本发明涉及包含分散在溶剂或溶剂混合物中的带电颜料颗粒的电泳分散体,其中颜料颗粒的平均聚集尺寸大于其初级尺寸的2倍。 本发明的电泳分散体能够通过调整带电颜料颗粒的聚集尺寸来提高图像的双稳性。

    System and a Method for Managing Device Identifier of A Ubiquitous Network
    7.
    发明申请
    System and a Method for Managing Device Identifier of A Ubiquitous Network 审中-公开
    用于管理无处不在网络的设备标识符的系统和方法

    公开(公告)号:US20130064201A1

    公开(公告)日:2013-03-14

    申请号:US13643892

    申请日:2011-03-08

    IPC分类号: H04W72/04

    摘要: The present invention discloses a ubiquitous network gateway, which includes: a conversion unit, used for converting the identifier of the device of the extension network of the ubiquitous network to the identifier of the communication network device, maintaining, storing or caching the mapping relationship between the identifier of the device of the extension network of the ubiquitous network and the identifier of the communication network device, and converting the identifier of the communication network device to the identifier of the device of the extension network of the ubiquitous network; an identifier mapping unit, used for maintaining or storing the mapping relationships among the identifier of the device of the extension network of the ubiquitous network, the identifier of the communication network device and the gateway identifiers of the ubiquitous network. A system and a method for managing communication network device identifiers of the ubiquitous network are disclosed in the present invention. The use of the ubiquitous network gateway, system and method of the present invention can enable the service interaction with the device of the extension network of the ubiquitous network and benefit the service development of the ubiquitous network.

    摘要翻译: 本发明公开了一种无所不在的网络网关,包括:转换单元,用于将无处不在网络的扩展网络的设备的标识符转换为通信网络设备的标识符,维护,存储或缓存映射关系的映射关系 无处不在网络的扩展网络的设备的标识符和通信网络设备的标识符,并将通信网络设备的标识符转换为无所不在的网络的扩展网络的设备的标识符; 标识符映射单元,用于维护或存储无处不在网络的扩展网络的设备的标识符,通信网络设备的标识符和无所不在的网络的网关标识符之间的映射关系。 在本发明中公开了一种用于管理普遍存在的网络的通信网络设备标识符的系统和方法。 本发明的无处不在的网络网关,系统和方法的使用可以实现与无处不在网络的扩展网络的设备的服务交互,有利于无所不在的网络的业务发展。

    Reagents for the Detection of Protein Phosphorylation in Carcinoma Signaling Pathways
    8.
    发明申请
    Reagents for the Detection of Protein Phosphorylation in Carcinoma Signaling Pathways 审中-公开
    用于检测癌症信号通路中蛋白质磷酸化的试剂

    公开(公告)号:US20110105732A1

    公开(公告)日:2011-05-05

    申请号:US12985879

    申请日:2011-01-06

    IPC分类号: C07K16/18

    摘要: The invention discloses 214 novel phosphorylation sites identified in signal transduction proteins and pathways underlying human carcinoma, and provides phosphorylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these phosphorylated sites/proteins, as well as methods of using the reagents for such purpose. Among the phosphorylation sites identified are sites occurring in the following protein types: Adaptor/Scaffold proteins, Cytoskeleton proteins, GTP Signaling proteins, Kinases, Metabolism proteins, Phosphatases/Phospho-diesterases/Proteases, Receptor proteins, RNA Processing proteins, Transcription proteins, Translation proteins, Transporter proteins, and Ubitquitin proteins, as well as other protein types.

    摘要翻译: 本发明公开了在信号转导蛋白中鉴定的214个新的磷酸化位点和人癌基因的途径,并提供磷酸化位点特异性抗体和重同位素标记肽(AQUA肽),用于选择性检测和定量这些磷酸化位点/蛋白质 作为使用试剂用于此目的的方法。 鉴定的磷酸化位点是发生在以下蛋白质类型中的位点:适配器/支架蛋白,细胞骨架蛋白,GTP信号蛋白,激酶,代谢蛋白,磷酸酶/磷酸二酯酶/蛋白酶,受体蛋白,RNA加工蛋白,转录蛋白,翻译 蛋白质,转运蛋白和Ubitquitin蛋白质,以及其他蛋白质类型。